Posts

Showing posts with the label Postpartum depression (PPD) competitive landscape

Postpartum depression (PPD) – Market outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2021 To 2032

Image
  Postpartum depression (PPD) is a severe health issue affecting about 15% of the female population after giving birth. It often conveys significant adverse consequences to the offspring. The symptoms and risk factors are similar to those found in non-postpartum depression. The main difference is that PPD is triggered by postpartum-specific factors, including biological changes in hormone levels. PPD is under-recognized and undertreated. The obstetrician and pediatrician serve essential roles in screening for and treating PPD. Treatment options include psychotherapy and antidepressant medication. Obstacles to compliance with treatment recommendations have access to psychotherapists and breastfeeding mothers' concerns about the infant's exposure to antidepressant medication.   Postpartum depression (PPD) affects between 6.5 and 20% of women. It is more common in adolescent girls, moms with premature newborns, and women who reside in cities.   The competitive landsc...